Trevi Therapeutics, Inc. TRVI Granted (in shares)
Granted (in shares) at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s granted (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s granted (in shares)?
- Trevi Therapeutics, Inc. (TRVI) reported granted (in shares) of 3.2M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s granted (in shares) changed year-over-year?
- Trevi Therapeutics, Inc.'s granted (in shares) increased by 27.2% year-over-year, from 2.5M to 3.2M.
- What does granted (in shares) mean?
- The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.